A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Esperion Therapeutics, Inc.
- Study ID
- NCT05694260
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Bempedoic acid — DRUGOnce daily oral dosing with oral tablets.
Study Details
Multiple-dose study to measure pharmacokinetics, pharmacodynamics and safety of bempedoic acid in pediatric participants 6 to 17 years of age with HeFH.
Key Dates
- First listed
- Jan 23, 2023
- Start date
- Jan 12, 2023
- Status verified
- Jul 2026
- Primary completion
- Jun 4, 2025
- Completion
- Jun 4, 2025
Study Design
- Enrollment
- 31 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Cohort 1Participants at 16 to \<30 kilograms (kg) body weight at screening receiving once daily 60 milligrams (mg) bempedoic acid for 8 weeks followed by 90 mg bempedoic acid for 8 weeks.
- Experimental: Cohort 2Participants at 30 to 60 kg body weight at screening receiving once daily120 mg bempedoic acid for 8 weeks followed by 150 mg bempedoic acid for 8 weeks.
- Experimental: Cohort 3Participants at greater than 60 kg body weight at screening receiving once daily 180 mg bempedoic acid for 8 weeks.
Primary Outcome Measure
Observed Trough Plasma Concentration of ETC-1002 Following 8 Weeks of Steady State Dosing of Bempedoic Acid [ Time Frame: Week 8 pre-dose ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | - |
| Providere Research Inc | West Covina | California | 91790 | - |
| Excel Medical Clinical Trials, LLC | Boca Raton | Florida | 33434 | - |
| Washington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research | St Louis | Missouri | 63110 | - |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | - |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | - |
| Cardiology Care for Children | Lancaster | Pennsylvania | 17601 | - |
| University of Utah and Primary Children's Hospital | Salt Lake City | Utah | 84113 | - |
Find similar trials in Los Angeles, CA
By research site
Cedars-Sinai Medical Center· Los Angeles, CAProvidere Research Inc· West Covina, CAExcel Medical Clinical Trials, LLC· Boca Raton, FLWashington University School of Medicine, Division of Endocrinology, Metabolism and Lipid Research· St Louis, MOWake Forest University Health Sciences· Winston-Salem, NCCincinnati Children's Hospital Medical Center· Cincinnati, OH
Related Studies
- Phase 1b Study of VERVE-201 in Patients With Refractory HyperlipidemiaPHASE1 · Recruiting · Verve Therapeutics, Inc. · Clearwater, Florida
- Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders TrialPHASE2 · Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Pharmacogenomic Informed Statin PrescribingRecruiting · VA Office of Research and Development · Indianapolis, Indiana
- Vascular Intervention Strategies Trial for Alzheimer'sPHASE2 · Not Yet Recruiting · University of Southern California · Los Angeles, California